BFRI ▲ +3.2% - Biofrontera Inc. $BFRI BFRIW - Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full Body 08-OCT-2026 09:22 AM ET